Search Results - "Verdoes, M."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells by Rückrich, T, Kraus, M, Gogel, J, Beck, A, Ovaa, H, Verdoes, M, Overkleeft, H S, Kalbacher, H, Driessen, C

    Published in Leukemia (01-06-2009)
    “…Resistance towards the proteasome inhibitor bortezomib is poorly understood. We adapted the HL-60, ARH-77 and AMO-1 cell lines (myeloid leukemia, plasmocytoid…”
    Get full text
    Journal Article
  2. 2

    Effect of Antigen Valency on Autoreactive B‑Cell Targeting by van Weijsten, M. J., Venrooij, K. R., Lelieveldt, L.P.W.M., Kissel, T., van Buijtenen, E., van Dalen, F. J., Verdoes, M., Toes, R.E.M., Bonger, K. M.

    Published in Molecular pharmaceutics (05-02-2024)
    “…Many autoimmune diseases are characterized by B cells that mistakenly recognize autoantigens and produce antibodies toward self-proteins. Current therapies aim…”
    Get full text
    Journal Article
  3. 3

    The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Cathepsin K by Mons, Elma, Jansen, Ineke D. C, Loboda, Jure, van Doodewaerd, Bjorn R, Hermans, Jill, Verdoes, Martijn, van Boeckel, Constant A. A, van Veelen, Peter A, Turk, Boris, Turk, Dusan, Ovaa, Huib

    Published in Journal of the American Chemical Society (27-02-2019)
    “…Irreversible covalent inhibitors can have a beneficial pharmacokinetic/pharmacodynamics profile but are still often avoided due to the risk of indiscriminate…”
    Get full text
    Journal Article
  4. 4

    Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib by Ovaa, Huib, Berkers, Celia R, Verdoes, Martijn, Lichtman, Eben, Fiebiger, Edda, Kessler, Benedikt M, Anderson, Kenneth C, Ploegh, Hidde L, Galardy, Paul J

    Published in Nature methods (01-05-2005)
    “…Proteasome inhibitors, such as the dipeptide boronic acid bortezomib, are emerging as important tools in the treatment of the fatal hematologic malignancy…”
    Get full text
    Journal Article
  5. 5

    An Unusual Reverse Turn Structure Adopted by a Furanoid Sugar Amino Acid Incorporated in Gramicidin S by Grotenbreg, Gijsbert M, Timmer, Mattie S. M, Llamas-Saiz, Antonio L, Verdoes, Martijn, van der Marel, Gijsbert A, van Raaij, Mark J, Overkleeft, Herman S, Overhand, Mark

    Published in Journal of the American Chemical Society (24-03-2004)
    “…A new reverse turn, replacing one of the native type II‘ β-turns in the cyclic peptide antibiotic gramicidin S, induced by a furanoid sugar amino acid is…”
    Get full text
    Journal Article
  6. 6

    Synthesis of functionalized heterocycles via a tandem Staudinger/aza-Wittig/Ugi multicomponent reaction by Timmer, Mattie S.M., Risseeuw, Martijn D.P., Verdoes, Martijn, Filippov, Dmitri V., Plaisier, Jasper R., van der Marel, Gijsbert A., Overkleeft, Herman S., van Boom, Jacques H.

    Published in Tetrahedron: asymmetry (01-01-2005)
    “…[Display omitted] By combining a Staudinger/aza-Wittig and an Ugi three-component reaction in a one-pot process (SAWU-3CR), a new and efficient multicomponent…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The Use of a Mannitol-Derived Fused Oxacycle as a Combinatorial Scaffold by Timmer, Mattie S. M, Verdoes, Martijn, Sliedregt, Leo A. J. M, van der Marel, Gijsbert A, van Boom, Jacques H, Overkleeft, Herman S

    Published in Journal of organic chemistry (28-11-2003)
    “…An efficient and high-yielding solid-phase synthesis of a small library of compounds containing a cis-fused pyranofuran structural motive is descibed. With use…”
    Get full text
    Journal Article
  9. 9